Dillard's Inc
NYSE:DDS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
294.77
700.627
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one
DDS
stock under the Base Case scenario is
404.31
USD.
Compared to the current market price of 603.46 USD,
Dillard's Inc
is
Overvalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Dillard's Inc.
| ZA |
W
|
Woolworths Holdings Ltd
JSE:WHL
|
|
| UK |
|
Next PLC
LSE:NXT
|
|
| MX |
|
El Puerto de Liverpool SAB de CV
BMV:LIVEPOLC-1
|
|
| CN |
C
|
CCOOP Group Co Ltd
SZSE:000564
|
|
| US |
|
Macy's Inc
NYSE:M
|
|
| JP |
|
Isetan Mitsukoshi Holdings Ltd
TSE:3099
|
|
| US |
|
Nordstrom Inc
NYSE:JWN
|
|
| JP |
J
|
J.Front Retailing Co Ltd
TSE:3086
|
|
| JP |
|
Takashimaya Co Ltd
TSE:8233
|
|
| CN |
|
Easyhome New Retail Group Co Ltd
SZSE:000785
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Dillard's Inc
Balance Sheet Decomposition
Dillard's Inc
| Current Assets | 3.2B |
| Cash & Short-Term Investments | 1.3B |
| Receivables | 44.9m |
| Other Current Assets | 1.8B |
| Non-Current Assets | 1.1B |
| PP&E | 971m |
| Other Non-Current Assets | 158.1m |
| Current Liabilities | 1.4B |
| Accounts Payable | 1.2B |
| Accrued Liabilities | 10m |
| Other Current Liabilities | 221.4m |
| Non-Current Liabilities | 807.6m |
| Long-Term Debt | 425.7m |
| Other Non-Current Liabilities | 381.9m |
Free Cash Flow Analysis
Dillard's Inc
| USD | |
| Free Cash Flow | USD |
Earnings Waterfall
Dillard's Inc
|
Revenue
|
6.6B
USD
|
|
Cost of Revenue
|
-4B
USD
|
|
Gross Profit
|
2.7B
USD
|
|
Operating Expenses
|
-2B
USD
|
|
Operating Income
|
699.7m
USD
|
|
Other Expenses
|
-118.9m
USD
|
|
Net Income
|
580.9m
USD
|
DDS Profitability Score
Profitability Due Diligence
Dillard's Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
Score
Dillard's Inc's profitability score is 61/100. The higher the profitability score, the more profitable the company is.
DDS Solvency Score
Solvency Due Diligence
Dillard's Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Score
Dillard's Inc's solvency score is 74/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
DDS Price Targets Summary
Dillard's Inc
According to Wall Street analysts, the average 1-year price target for
DDS
is 572.56 USD
with a low forecast of 464.6 USD and a high forecast of 735 USD.
Dividends
Current shareholder yield for
DDS is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
DDS
stock under the Base Case scenario is
404.31
USD.
Compared to the current market price of 603.46 USD,
Dillard's Inc
is
Overvalued by 33%.